IL6 and cancer: Our studies focused specifically on the dUTPase, since we previously showed that the HERV-K dUTPase can induce IL-6, and IL-6 has been implicated in EndMT in experimental pulmonary hypertension (18) and in epithelial-mesenchymal transition in cancer cells (50).